Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	1,045,427	876,631	891,926	1,013,630	497,549	356,774
Market Cap Growth	16.41%	-1.71%	-12.01%	103.72%	39.46%	-20.96%
Enterprise Value	1,123,171	930,186	892,181	1,022,435	525,557	387,118
Last Close Price	1038.95	871.20	876.36	993.46	480.30	338.10
PE Ratio	20.74	17.39	19.71	26.26	25.38	7.95
Forward PE	25.23	20.54	19.01	28.46	21.39	16.57
PS Ratio	3.85	3.23	3.84	5.19	2.89	2.36
PB Ratio	3.53	2.96	3.38	4.59	2.53	1.87
P/TBV Ratio	10.77	9.03	5.76	8.48	4.28	3.40
P/FCF Ratio	-	-	17.61	44.27	30.01	39.56
P/OCF Ratio	49.39	41.42	13.16	31.71	18.50	16.95
PEG Ratio	3.55	2.29	2.15	1.53	1.79	3.03
EV/Sales Ratio	4.14	3.43	3.84	5.23	3.05	2.56
EV/EBITDA Ratio	15.27	12.82	13.06	19.45	14.87	12.21
EV/EBIT Ratio	19.09	16.08	14.97	22.53	18.42	15.65
EV/FCF Ratio	-87.93	-	17.62	44.65	31.70	42.92
Debt / Equity Ratio	0.42	0.42	0.12	0.04	0.06	0.22
Debt / EBITDA Ratio	1.72	1.72	0.47	0.16	0.34	1.33
Debt / FCF Ratio	-	-	0.64	0.36	0.72	4.68
Net Debt / Equity Ratio	0.18	0.18	-0.09	-0.02	0	0.01
Net Debt / EBITDA Ratio	0.73	0.73	-0.35	-0.10	0.00	0.08
Net Debt / FCF Ratio	-4.15	-4.15	-0.48	-0.23	0.00	0.27
Asset Turnover	0.61	0.61	0.70	0.71	0.64	0.59
Inventory Turnover	1.52	1.52	1.77	1.87	1.81	1.64
Quick Ratio	0.80	0.80	1.12	1.30	1.05	0.96
Current Ratio	1.27	1.27	1.89	2.14	1.81	1.54
Return on Equity (ROE)	18.32%	18.32%	19.28%	18.90%	10.82%	13.96%
Return on Assets (ROA)	8.07%	8.07%	11.21%	10.31%	6.66%	5.98%
Return on Invested Capital (ROIC)	13.47%	15.00%	20.11%	17.64%	11.43%	10.78%
Return on Capital Employed (ROCE)	15.80%	15.80%	21.20%	19.00%	14.10%	12.40%
Earnings Yield	4.82%	5.75%	5.07%	3.81%	3.94%	12.58%
FCF Yield	-1.22%	-1.46%	5.68%	2.26%	3.33%	2.53%
Dividend Yield	0.10%	0.11%	1.26%	0.30%	1.25%	0.74%
Payout Ratio	21.95%	21.95%	6.68%	16.09%	13.63%	8.29%
Buyback Yield / Dilution	0.00%	0.00%	0.56%	0.37%	0.79%	-
Total Shareholder Return	0.10%	0.12%	1.82%	0.67%	2.04%	0.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.